| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |